Henry Schein names new chief commercial officer

Henry Schein has announced the appointment of Dave McKinley to the newly-created position of chief commercial officer.

Mr McKinley, the current president of Henry Schein's medical business, will also serve as president of its newly formed corporate commercial development group, taking responsibility for global corporate marketing, product category management, technology initiatives and certain specialty businesses.

This comes as part of a reorganisation of the firm's senior executive team, with the aim of improving its commercial capabilities and driving growth opportunities.

Karen Prange, senior vice-president at Boston Scientific, will be joining Henry Schein as its new executive vice-president and chief executive officer of its global animal health and medical group.

She will also be in charge of the global dental surgical group when she joins the company on May 17th.

Stanley Bergman, chairman of the board and chief executive officer of Henry Schein, said: "We have created these new positions at a time when market, technological and demographic forces are converging to create unique business opportunities for Henry Schein."